Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Asset Writedowns and Impairment (2020 - 2024)

Insight Molecular Diagnostics' Asset Writedowns and Impairment history spans 3 years, with the latest figure at $36.9 million for Q4 2024.

  • On a quarterly basis, Asset Writedowns and Impairment rose 922600.0% to $36.9 million in Q4 2024 year-over-year; TTM through Dec 2024 was $38.7 million, a 472.1% increase, with the full-year FY2025 number at $14.6 million, down 65.16% from a year prior.
  • Asset Writedowns and Impairment hit $36.9 million in Q4 2024 for Insight Molecular Diagnostics, up from -$4000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for IMDX hit a ceiling of $36.9 million in Q4 2024 and a floor of -$334000.0 in Q3 2020.
  • Historically, Asset Writedowns and Impairment has averaged $5.5 million across 3 years, with a median of $333500.0 in 2020.
  • The widest YoY moves for Asset Writedowns and Impairment: up 922600.0% in 2024, down 922600.0% in 2024.
  • Tracing IMDX's Asset Writedowns and Impairment over 3 years: stood at $334000.0 in 2020, then tumbled by 101.2% to -$4000.0 in 2023, then surged by 922600.0% to $36.9 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for IMDX at $36.9 million in Q4 2024, -$4000.0 in Q4 2023, and $1.8 million in Q3 2023.